Ventricular Tachycardia (VT) is an abnormal heart rhythm marked by a rapid and sustained heartbeat originating in the ventricles, the heart's lower chambers. This condition results in a disruption of the heart's normal electrical activity, leading to a significantly elevated heart rate. Ventricular Tachycardia poses a serious medical concern, as it can compromise the heart's ability to pump blood effectively, potentially leading to complications such as dizziness, fainting, or even cardiac arrest. While Ventricular Tachycardia is often associated with underlying heart conditions like coronary artery disease or structural abnormalities, it can also manifest in individuals with structurally normal hearts. The exact cause may vary, including scar tissue from a previous heart attack, genetic factors, or certain medications.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States